Balanced Pharma Inc

Amendment

CIK: 0001838860·Pharmaceuticals·DELAWARE·Filed: Feb 18, 2022

Total Offering

$2,011,300

Amount Sold

$2,011,300

Investors

44

First Sale

Dec 16, 2020

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2020
Non-Accredited Investors: No

Related Persons

Name	Role
JOHN SCOTT KEADLE	Related Person
JOHN SELIG	Related Person

Company

Balanced Pharma Inc

18204 MAINSAIL POINTE

CORNELIUS, NC, 28031

(704) 650-0249

SEC Filing

0001838860-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.